Sei Investments Co. Sells 3,700 Shares of TruBridge, Inc. (NASDAQ:TBRG)

Sei Investments Co. lessened its stake in TruBridge, Inc. (NASDAQ:TBRG) by 19.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,640 shares of the company’s stock after selling 3,700 shares during the quarter. Sei Investments Co. owned about 0.10% of TruBridge worth $308,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Truffle Hound Capital LLC bought a new position in TruBridge during the 4th quarter worth approximately $5,916,000. Geode Capital Management LLC acquired a new stake in TruBridge during the 3rd quarter worth $1,747,000. Charles Schwab Investment Management Inc. bought a new position in TruBridge during the third quarter worth about $875,000. State Street Corp acquired a new position in TruBridge in the third quarter valued at about $829,000. Finally, JPMorgan Chase & Co. increased its holdings in shares of TruBridge by 73.4% in the third quarter. JPMorgan Chase & Co. now owns 112,240 shares of the company’s stock worth $1,342,000 after acquiring an additional 47,507 shares in the last quarter. Institutional investors and hedge funds own 88.64% of the company’s stock.

TruBridge Stock Performance

Shares of NASDAQ TBRG opened at $24.54 on Friday. The stock has a market capitalization of $366.85 million, a PE ratio of -6.00, a price-to-earnings-growth ratio of 5.38 and a beta of 0.64. TruBridge, Inc. has a 52 week low of $7.61 and a 52 week high of $32.00. The stock has a 50 day moving average price of $27.47 and a 200 day moving average price of $20.71. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Cantor Fitzgerald lifted their price target on shares of TruBridge from $20.00 to $29.00 and gave the company an “overweight” rating in a research note on Tuesday, March 11th. Stephens reaffirmed an “equal weight” rating and issued a $28.00 target price on shares of TruBridge in a research note on Thursday.

Insider Buying and Selling

In other TruBridge news, major shareholder Pinetree Capital Ltd. purchased 6,795 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $28.16 per share, with a total value of $191,347.20. Following the acquisition, the insider now directly owns 729,176 shares of the company’s stock, valued at $20,533,596.16. This trade represents a 0.94 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Christopher L. Fowler sold 5,100 shares of the company’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $27.02, for a total transaction of $137,802.00. Following the completion of the transaction, the chief executive officer now owns 142,939 shares in the company, valued at approximately $3,862,211.78. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have bought 116,728 shares of company stock worth $3,239,879. Insiders own 10.70% of the company’s stock.

About TruBridge

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.